The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-((5-Fluoro-4-methylpyridin-2-yl)amino)-4-((2-methoxy-3-(1,3,4-oxadiazol-2-yl)phenyl)amino)-N-methylnicotinamide ID: ALA4543984
PubChem CID: 90154028
Max Phase: Preclinical
Molecular Formula: C22H20FN7O3
Molecular Weight: 449.45
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CNC(=O)c1cnc(Nc2cc(C)c(F)cn2)cc1Nc1cccc(-c2nnco2)c1OC
Standard InChI: InChI=1S/C22H20FN7O3/c1-12-7-18(26-10-15(12)23)29-19-8-17(14(9-25-19)21(31)24-2)28-16-6-4-5-13(20(16)32-3)22-30-27-11-33-22/h4-11H,1-3H3,(H,24,31)(H2,25,26,28,29)
Standard InChI Key: VICBYAZWSYIJBT-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 36 0 0 0 0 0 0 0 0999 V2000
4.6747 -7.4207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6736 -8.2403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3816 -8.6492 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0913 -8.2398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0885 -7.4171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3798 -7.0119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7996 -8.6473 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5067 -8.2376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2117 -8.6455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9183 -8.2365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9175 -7.4184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2041 -7.0111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5005 -7.4224 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6240 -7.0077 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.3774 -6.1947 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9669 -7.0123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9667 -6.1951 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2593 -7.4211 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5515 -7.0126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0839 -5.7840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7907 -6.1928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4967 -5.7828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4947 -4.9647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7808 -4.5584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0777 -4.9708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3671 -4.5673 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6623 -4.9810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6265 -8.6443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7755 -3.7413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4324 -3.2603 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1748 -2.4848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3576 -2.4901 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1103 -3.2689 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
11 14 1 0
6 15 1 0
1 16 1 0
16 17 2 0
16 18 1 0
18 19 1 0
15 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
25 26 1 0
26 27 1 0
10 28 1 0
24 29 1 0
29 30 1 0
30 31 1 0
31 32 2 0
32 33 1 0
33 29 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 449.45Molecular Weight (Monoisotopic): 449.1612AlogP: 3.83#Rotatable Bonds: 7Polar Surface Area: 127.09Molecular Species: NEUTRALHBA: 9HBD: 3#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.20CX Basic pKa: 6.91CX LogP: 3.49CX LogD: 3.47Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.39Np Likeness Score: -1.30
References 1. Wrobleski ST, Moslin R, Lin S, Zhang Y, Spergel S, Kempson J, Tokarski JS, Strnad J, Zupa-Fernandez A, Cheng L, Shuster D, Gillooly K, Yang X, Heimrich E, McIntyre KW, Chaudhry C, Khan J, Ruzanov M, Tredup J, Mulligan D, Xie D, Sun H, Huang C, D'Arienzo C, Aranibar N, Chiney M, Chimalakonda A, Pitts WJ, Lombardo L, Carter PH, Burke JR, Weinstein DS.. (2019) Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165., 62 (20): [PMID:31318208 ] [10.1021/acs.jmedchem.9b00444 ]